Summary & Overview
HCPCS G4023: Pathology MIPS Specialty Set
HCPCS Level II code G4023 identifies the Pathology MIPS specialty set, a quality-measurement designation used for pathology clinicians participating in the Merit-based Incentive Payment System (MIPS). As a specialty set code, G4023 is used to represent aggregated pathology-specific performance measures that inform quality reporting and program adjustments under federal value-based payment frameworks. Nationally, pathology MIPS measures influence practice-level reporting burdens and tie into broader payment adjustments for clinicians.
Key payers included in this overview are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what the code represents, the expected service context and sites of service, and what to expect in terms of the content of a full publication: national benchmarks where available, relevant policy updates affecting MIPS specialty sets, and clinical context about pathology measure reporting. The summary notes where input data is not present: details such as associated taxonomies, ICD-10 diagnoses, related codes, and granular payer-specific coverage policy were not provided in the input.
This publication is intended to orient clinicians, billing staff, and policy analysts to the purpose and scope of G4023, and to preview the types of benchmark and policy information a full analysis will include.
Billing Code Overview
HCPCS Level II code G4023 is designated as the Pathology MIPS specialty set. This code represents a specialty measure set used in the context of the Medicare Quality Payment Program's Merit-based Incentive Payment System (MIPS) specifically for pathology practitioners and services.
-
Service Type: Quality measurement and reporting related to pathology practice
-
Typical Site of Service: Pathology laboratories, hospital-based pathology departments, and outpatient pathology practices
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A pathology practice participates in the Medicare Merit-based Incentive Payment System (MIPS) Specialty Set reporting under billing code G4023. This applies when a pathology group reports quality measures, improvement activities, and advancing care information for MIPS under the pathology specialty set for a reporting period. Typical workflow: specimen accessioning and diagnostic interpretation by a board-certified pathologist; extraction and submission of required MIPS measure data to the designated Qualified Clinical Data Registry (QCDR) or Medicare via the group’s electronic health record or registry; documentation of measure numerator/denominator criteria in the pathology report and practice quality records; and attestation and submission during the MIPS reporting window. A representative patient scenario: an adult undergoing tissue biopsy for a suspected malignancy; the specimen is processed by the pathology lab, a histopathology report is generated with diagnostic codes, and the pathology group includes this case in its MIPS specialty set measure reporting to demonstrate adherence to quality and reporting requirements for the performance year.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased Procedural Services | Use when the pathology service required substantially greater resources than typical and documentation supports increased complexity. |